Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
89000218 | 8900021 | 8 | F | 2009 | 20160822 | 20121109 | 20160826 | EXP | PHHY2012BR102176 | NOVARTIS | 0.00 | F | Y | 65.00000 | KG | 20160826 | MD | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
89000218 | 8900021 | 1 | PS | EXJADE | DEFERASIROX | 1 | Oral | 3 DF, QD | Y | 21882 | 3 | DF | DISPERSIBLE TABLET | QD | |||||
89000218 | 8900021 | 2 | SS | EXJADE | DEFERASIROX | 1 | Oral | 1 DF, UNK | Y | 21882 | 1 | DF | DISPERSIBLE TABLET | ||||||
89000218 | 8900021 | 3 | SS | EXJADE | DEFERASIROX | 1 | Oral | 2 DF, QD | Y | 21882 | 2 | DF | DISPERSIBLE TABLET | QD | |||||
89000218 | 8900021 | 4 | SS | EXJADE | DEFERASIROX | 1 | Oral | 3 DF, QD | Y | SA055 | 21882 | 3 | DF | DISPERSIBLE TABLET | QD | ||||
89000218 | 8900021 | 5 | C | ENDOFOLIN | FOLIC ACID | 1 | Oral | 2 DF, DAILY | 0 | 2 | DF | QD | |||||||
89000218 | 8900021 | 6 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 2 DF, DAILY | 0 | 2 | DF | QD | |||||||
89000218 | 8900021 | 7 | C | HYDREA | HYDROXYUREA | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
89000218 | 8900021 | 8 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | UNK | 0 | ||||||||||
89000218 | 8900021 | 9 | C | CLORANA | HYDROCHLOROTHIAZIDE | 1 | Oral | 2 DF, DAILY | 0 | 2 | DF | ||||||||
89000218 | 8900021 | 10 | C | ATENOLOL W/NIFEDIPINE | 2 | Unknown | UNK | 0 | |||||||||||
89000218 | 8900021 | 11 | C | AAS | ASPIRIN | 1 | Unknown | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
89000218 | 8900021 | 1 | Sickle cell anaemia |
89000218 | 8900021 | 5 | Product used for unknown indication |
89000218 | 8900021 | 6 | Product used for unknown indication |
89000218 | 8900021 | 7 | Sickle cell anaemia |
89000218 | 8900021 | 8 | Product used for unknown indication |
89000218 | 8900021 | 9 | Product used for unknown indication |
89000218 | 8900021 | 10 | Product used for unknown indication |
89000218 | 8900021 | 11 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
89000218 | 8900021 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
89000218 | 8900021 | Asthenia | |
89000218 | 8900021 | Blood iron increased | |
89000218 | 8900021 | Diarrhoea | |
89000218 | 8900021 | Dysgeusia | |
89000218 | 8900021 | Dysphagia | |
89000218 | 8900021 | Hypertension | |
89000218 | 8900021 | Limb discomfort | |
89000218 | 8900021 | Liver disorder | |
89000218 | 8900021 | Malaise | |
89000218 | 8900021 | Musculoskeletal discomfort | |
89000218 | 8900021 | Nail discolouration | |
89000218 | 8900021 | Nephrolithiasis | |
89000218 | 8900021 | Osteonecrosis | |
89000218 | 8900021 | Pyrexia | |
89000218 | 8900021 | Renal disorder | |
89000218 | 8900021 | Skin discolouration | |
89000218 | 8900021 | Syncope | |
89000218 | 8900021 | Vomiting | |
89000218 | 8900021 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
89000218 | 8900021 | 1 | 2005 | 0 | ||
89000218 | 8900021 | 2 | 201112 | 201208 | 0 | |
89000218 | 8900021 | 5 | 19920101 | 0 | ||
89000218 | 8900021 | 6 | 20111212 | 0 | ||
89000218 | 8900021 | 7 | 2005 | 0 | ||
89000218 | 8900021 | 8 | 1992 | 0 | ||
89000218 | 8900021 | 9 | 2002 | 0 | ||
89000218 | 8900021 | 11 | 2012 | 0 |